Бизнес · 05.11.20261 мин чтения
Telix Joins Thera4Care with TLX400-Tx to Accelerate Translation of Next Generation FAP-Targeting Theranostics
Локальный автоматический перевод · Язык оригинального источника
Краткое содержание
Thera4Care is an initiative aimed at establishing an integrated theranostics ecosystem to broaden patient access in Europe Telix's fibroblast activation protein (FAP) targeting therapy candidate (TLX400-Tx) has been…